Close Menu

The Scan

Retraction Watch reports that a fourth paper linked to the STAP stem cell scandal has now been retraction.

To Find a Reason

A Columbia University doctor is seeking to use nanopore sequencing to uncover the cause of recurrent miscarriages, reports NBC News.

In Nature this week: review of scientific, technical, and ethical aspects of therapeutic genome editing; fitness consequence map for rice; and more.

Odd Little Virus

Researchers in Brazil have uncovered a virus that infects amoebas that is unlike any known virus, Live Science reports.

NPR reports on how new genetic tools may speed 2019-nCoV vaccine development.

TechCrunch reports that a California state senator is introducing a bill to increase the regulation of direct-to-consumer genetic testing companies.

In Genome Research this week: analysis of gene regulation in primates, direct RNA sequencing of C. elegans, more.

The Trump Administration's budget proposal for fiscal year 2021 calls for an 8 percent cut to the US National Institutes of Health budget.

Not This Trial

Two experimental drugs were unable to slow or prevent Alzheimer's disease among people at high genetic risk, the Associated Press reports.

Slower Times

CNBC discusses factors contributing to the state of direct-to-consumer genetic testing. 

In PNAS this week: immune gene expression differences in blood of young adults, molecular contributors to cells' microtubule and actin networks, and more.

The genome of a woolly mammoth from an isolated population exhibits a number of deleterious mutations, according to Gizmodo.

More Charges

According to NBC News, a former Emory professor who was fired last year for failing to disclose income from China is facing federal charges.

Tapering Suit

ScienceInsider reports six researchers are suing the Ludwig Institute for Cancer Research for "tapering" their funding. 

In PLOS this week: signs of selection on microRNA targets, HPV sequences as markers of cervical cancer, and more.

Stanley Cohen Dies

Stanley Cohen who shared the 1986 Nobel Prize in Physiology or Medicine for his discovery of growth factors has died, according to the Tennessean.

New Scientist reports that cancer patients treated with immune cells that underwent CRISPR-based gene editing exhibited no serious side effects.

Li Wenliang, a Wuhan doctor who tried to warn others about a mysterious illness, has died of the coronavirus, the Guardian reports.

In Science this week: phase I study of CRISPR-based engineering of T cells for cancer patients, call for sewage-based global antimicrobial resistance surveillance system, and more.

Ancestry Layoffs

Ancestry is laying off about 6 percent of its workforce due to a decline in customer demand.

Code to Handle It

In a Nature commentary, researchers call for the development of an international code of conduct for genomics.

The US Food and Drug Administration has issued an emergency use authorization for a test for the 2019-nCoV coronavirus.

In Nature this week: new study of the Wuhan coronavirus suggests bats as the source of the outbreak, bioinformatic approach to identify cancer driver genes, and more.

Warrant Push Back

Ancestry challenged a search warrant it received seeking police access to its DNA database, according to Buzzfeed News.

DNA analysis finds that jetsam ambergris comes from sperm whales, the New York Times reports.


In PLOS this week: transcriptomic and genomic analysis of prostate cancer by ancestry, genes linked to liver function in Korean cohort, and more.

British Columbia is incorporating genomics into its tracking of the ongoing COVID-19 outbreak, Business in Vancouver reports.

An analysis by the Personalized Medicine Coalition finds that about a quarter of new drugs approved in 2019 by the US Food and Drug Administration were personalized medicines.

The governor of New York has proposed a five-year plan to study the genomes of people with or who are at high risk of developing Alzheimer's disease.